person · Reporting owner
Huffines Robert Luther
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Director | August 06, 2026 | August 06, 2026 |
| Eikon Therapeutics, Inc.EIKN · Entity 5380 | Director | March 02, 2026 | March 04, 2026 |
| INSULET CORPPODD · Entity 3516 | Director | September 30, 2026 | October 03, 2026 |
| Solid Biosciences Inc.SLDB · Entity 4915 | Director | December 13, 2022 | December 15, 2022 |
| Walgreens Boots Alliance, Inc.WBA · Entity 16467 | Director | August 13, 2025 | August 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date August 06, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Rights to Common Stock Under BD Deferred Compensation PlanSEC Table II · derivative / convertible security | Direct | 595 |
Reported balance
After 2026-08-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-06 · Grant · Acquired 189 · Balance 595 F1: The securities convert to common stock on a one-for-one basis. F2: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3: Includes rights acquired through dividend investment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities convert to common stock on a one-for-one basis.
F2: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.
F3: Includes rights acquired through dividend investment since the last report filed by the reporting person.
Eikon Therapeutics, Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.88 · Expires 2036-03-01 | Direct | 25,873 |
Reported balance
After 2026-03-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 25,873 · Balance 25,873 F1: 1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date.
INSULET CORP
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,627 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 178 · Balance 2,627 F1: These are deferred common stock units ("Deferred Units") received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The Deferred Units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: These are deferred common stock units ("Deferred Units") received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The Deferred Units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors.
Solid Biosciences Inc.
Report date December 13, 2022 · Filed December 15, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.47 · Expires 2032-12-13 | Direct | 9,650 |
Reported balance
After 2022-12-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-12-13 · Grant · Acquired 9,650 · Balance 9,650 F1: This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
Walgreens Boots Alliance, Inc.
Report date August 13, 2025 · Filed August 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 46,813.12 |
Reported balance
After 2025-08-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-13 · Grant · Acquired 16,820.86 · Balance 46,813.12 F1: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3: Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock.
F2: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan.
F3: Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:20 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 178 | $130.47 | $23,223.66 |
DisclosureSEC source: 0001145197-26-000183 · form4.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,627 F1 · shares: These are deferred common stock units ("Deferred Units") received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The Deferred Units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 06, 2026 Filed Aug 6, 2026 20:47 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 189 | $165.62 | $31,302.18 |
DisclosureSEC source: 0001628280-26-054422 · wk-form4_1786049274.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595 Underlying: Common Stock · 189 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:08 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 144 | $159.79 | $23,009.76 |
DisclosureSEC source: 0001145197-26-000153 · form4.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,442 F1 · shares: These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2026 Filed Jul 7, 2026 20:41 UTC Amendment | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 151 | $152.25 | $22,989.75 |
DisclosureSEC source: 0001145197-26-000159 · form4a.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,449 F1 · shares: These are deferred common stock units ("Deferred Units") received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The Deferred Units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. F2 · shares: Due to an administrative error, the wrong price per share was used to calculate the number of Deferred Units reported in the original Form 4. Accordingly, this amendment is being filed to correct the number of Deferred Units acquired (151 rather than 144 as originally reported) and the price per Deferred Unit ($152.25 rather than $159.79 as originally reported). F2 · price: Due to an administrative error, the wrong price per share was used to calculate the number of Deferred Units reported in the original Form 4. Accordingly, this amendment is being filed to correct the number of Deferred Units acquired (151 rather than 144 as originally reported) and the price per Deferred Unit ($152.25 rather than $159.79 as originally reported). Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:34 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001145197-26-000125 · form4.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,298 F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs, which will be settled in shares of common stock on a one-for-one basis, vest in full on April 30, 2027. The Reporting Person has elected to defer settlement of these RSUs pursuant to the Insulet Corporation Deferred Compensation Plan for Non-Employee Directors. Once vested, the shares will be issued in accordance with the Reporting Person's deferral election following the termination of the Reporting Person's service as a Director. Read SEC document |
| May 08, 2026 Filed May 8, 2026 21:26 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 210 | $149.04 | $31,298.40 |
DisclosureSEC source: 0001628280-26-033027 · wk-form4_1778275604.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404 Underlying: Common Stock · 210 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person. F4 · balance_after: Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:08 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 111 | $209.84 | $23,292.24 |
DisclosureSEC source: 0001145197-26-000091 · form4.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638 F1 · shares: These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:02 UTC | Eikon Therapeutics, Inc. EIKN · Entity 5380 | GrantStock Option (Right to Buy) · Derivative | 25,873 | $0.00 Strike: $14.88 | $0.00 |
DisclosureSEC source: 0001193125-26-091787 · ownership.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,873 Underlying: Common Stock · 25,873 shares Expires 2036-03-01 F1 · derivative.exercise_date: 1/48th of the shares underlying the option will vest on each monthly anniversary of the vesting start date for 48 months, subject to the Reporting Person's continued service through each date. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 17:24 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantRights to Common Stock Under BD Deferred Compensation Plan · Derivative | 100 | $201.91 | $20,191.00 |
DisclosureSEC source: 0001628280-26-005700 · wk-form4_1770312252.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 100 shares Expires not disclosed F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 14:50 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-004008 · wk-form4_1769698237.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,279 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person. Read SEC document |
| December 31, 2025 Filed Jan 6, 2026 21:38 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 50.8127 | $284.24 | $14,443.00 |
DisclosureSEC source: 0001145197-26-000004 · form4.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527.8127 F1 · shares: These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 19:55 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 180 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054700 · wk-form4_1764705302.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| October 31, 2025 Filed Nov 3, 2025 22:36 UTC | INSULET CORP PODD · Entity 3516 | GrantCommon Stock | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001145197-25-000062 · form4.xml · nonDerivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477 F1 · shares: Initial equity award in the form of restricted stock units ("RSUs"). RSUs fully vest on April 30, 2026. The RSUs are settled in shares of common stock on a one-for-one basis. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 22:18 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 16,820.86 | $11.89 | $200,000.03 |
DisclosureSEC source: 0001618921-25-000094 · wk-form4_1755296303.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,813.12 Underlying: Common Stock · 16,820.86 shares Expires not disclosed F1 · derivative.exercise_price: The annual phantom stock grant is issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan") in arrears with respect to services rendered over the course of the prior year, and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units. Read SEC document |
| July 09, 2025 Filed Jul 11, 2025 21:21 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 2,158.89 | $11.58 | $24,999.95 |
DisclosureSEC source: 0001618921-25-000063 · wk-form4_1752268863.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,992.26 Underlying: Common Stock · 2,158.89 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units. Read SEC document |
| April 16, 2025 Filed Apr 18, 2025 21:56 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 2,314.82 | $10.80 | $25,000.06 |
DisclosureSEC source: 0001618921-25-000042 · wk-form4_1745013381.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,833.37 Underlying: Common Stock · 2,314.82 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units that were issued in lieu of dividends on outstanding phantom stock units. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 00:29 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 2,181.5 | $11.46 | $24,999.99 |
DisclosureSEC source: 0001618921-25-000014 · wk-form4_1738628981.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,518.55 Underlying: Common Stock · 2,181.5 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. Amended and Restated 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through January 31, 2025) on outstanding phantom stock units. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 01:49 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 15,856.23 | $9.46 | $149,999.94 |
DisclosureSEC source: 0001618921-24-000123 · wk-form4_1730857757.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,752.45 Underlying: Common Stock · 15,856.23 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through October 31, 2024) on outstanding phantom stock units. Read SEC document |
| October 24, 2024 Filed Oct 28, 2024 21:02 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 2,676.66 | $9.34 | $25,000.00 |
DisclosureSEC source: 0001618921-24-000098 · wk-form4_1730149354.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,896.22 Underlying: Common Stock · 2,676.66 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through October 15, 2024) on outstanding phantom stock units. Read SEC document |
| July 10, 2024 Filed Jul 12, 2024 20:57 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 2,220.25 | $11.26 | $25,000.02 |
DisclosureSEC source: 0001618921-24-000069 · wk-form4_1720817836.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,103.51 Underlying: Common Stock · 2,220.25 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through July 1, 2024) on outstanding phantom stock units. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 22:02 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 1,420.45 | $17.60 | $24,999.92 |
DisclosureSEC source: 0001618921-24-000051 · wk-form4_1714428127.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,853.44 Underlying: Common Stock · 1,420.45 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F3 · balance_after: Includes phantom stock units issued in lieu of dividends (through April 15, 2024) on outstanding phantom stock units. Read SEC document |
| January 25, 2024 Filed Jan 29, 2024 23:11 UTC | Walgreens Boots Alliance, Inc. WBA · Entity 16467 | GrantPhantom Stock Units · Derivative | 427.96 | $23.11 | $9,890.16 |
DisclosureSEC source: 0001618921-24-000018 · wk-form4_1706569901.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427.96 Underlying: Common Stock · 427.96 shares Expires not disclosed F1 · derivative.exercise_price: The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder, the "Plan"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock. F2 · derivative.exercise_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. F2 · derivative.expiration_date: To be settled following termination of service as a director in accordance with the terms and conditions of the Plan. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 23:13 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 9,650 | $0.00 Strike: $6.47 | $0.00 |
DisclosureSEC source: 0000899243-22-038693 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,650 Underlying: Common Stock · 9,650 shares Expires 2032-12-13 F1 · derivative.exercise_date: This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 21:00 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 51,000 | $0.00 Strike: $0.63 | $0.00 |
DisclosureSEC source: 0001209191-22-035433 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 Underlying: Common Stock · 51,000 shares Expires 2032-06-07 F1 · derivative.exercise_date: This option was granted on June 7, 2022 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:00 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001209191-21-041936 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: This option was granted on June 16, 2021 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:14 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001209191-20-037564 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| June 13, 2019 Filed Jun 14, 2019 20:14 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $5.26 | $0.00 |
DisclosureSEC source: 0001209191-19-037122 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-13 F1 · derivative.exercise_date: This option was granted on June 13, 2019 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:05 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 8,165 | $0.00 Strike: $23.58 | $0.00 |
DisclosureSEC source: 0000899243-18-031200 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,165 Underlying: Common Stock · 8,165 shares Expires 2028-12-13 F1 · derivative.exercise_date: This option was granted on December 13, 2018 and vests in full on the earlier to occur of July 25, 2019 and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to I 00% of the unvested portion of such option upon specified change in control events. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 22:52 UTC | Solid Biosciences Inc. SLDB · Entity 4915 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,835 | $0.00 Strike: $37.89 | $0.00 |
DisclosureSEC source: 0000899243-18-020708 · doc4.xml · derivative · entry 1 Huffines Robert Luther · CIK 0001728221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,835 Underlying: Common Stock · 1,835 shares Expires 2028-07-25 F1 · derivative.exercise_date: This option was granted on July 25, 2018 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.